Trexquant Investment LP Immunic, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$8.05 - $13.29 $85,925 - $141,857	-10,674 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$11.76 - $16.85 $125,526 - $179,856	10,674 New	10,674 $131,000
Q1 2021 May 13, 2021	SELL	$14.21 - $25.3 $251,104 - $447,076	-17,671 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$14.8 - $20.37 $112,968 - $155,484	7,633 Added 76.04%	17,671 $270,000
Q3 2020 Nov 06, 2020	BUY	$11.74 - $22.0 $117,846 - $220,836	10,038 New	10,038 $186,000

56.3M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $29M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.